Lexaria Bioscience (LEXX) Total Debt (QoQ) (2012 - 2021)
Lexaria Bioscience (LEXX) Total Debt (QoQ) (2012 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Lexaria Bioscience | 10.15 Mn | 6.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2021 | 5.58% |
| May 31, 2021 | 0.00% |
| Feb 28, 2021 | -93.64% |
| Nov 30, 2020 | 32.07% |
| Aug 31, 2020 | 53.17% |
| May 31, 2020 | 3,546.94% |
| Feb 29, 2020 | -95.70% |
| Nov 30, 2019 | -22.65% |
| Aug 31, 2019 | 129.08% |
| May 31, 2019 | 273.51% |
| Feb 28, 2019 | -74.04% |
| Nov 30, 2018 | 175.67% |
| Aug 31, 2018 | -13.78% |
| May 31, 2018 | 62.85% |
| Feb 28, 2018 | -77.64% |
| Nov 30, 2017 | -41.40% |
| Aug 31, 2017 | 473.33% |
| May 31, 2017 | -97.37% |
| Feb 28, 2017 | -24.33% |
| Nov 30, 2016 | 12.71% |